Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma

Annals of Surgery

Volumn 253, Issue 5, 2011, Pages 900-911

  Memon, Muhammed Ashraf ^a,b,c,d   Subramanya, Manjunath S ^e   Khan, Shahjahan ^e   Hossain, Md Belal ^e   Osland, Emma ^a,e   Memon, Breda ^a  

^a IPSWICH HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c BOND UNIVERSITY   (Australia)

^d UNIVERSITY OF BOLTON   (United Kingdom)

^e UNIVERSITY OF SOUTHERN QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTOMOSIS LEAKAGE; ARTICLE; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE STUDY; GASTRECTOMY; HUMAN; LENGTH OF STAY; LYMPHADENECTOMY; META ANALYSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY CONTROL; REOPERATION; STOMACH ADENOCARCINOMA; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RISK ASSESSMENT; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79954633054     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e318212bff6     Document Type: Article

References (80)

1. Seto Y, Nagawa H, Muto T. Impact of lymph node metastasis on survival with early gastric cancer. World J Surg. 1997;21:186-189.
2. Siewert JR, B̈ottcher K, Stein HJ, et al. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg. 1998;228:449-461. (Pubitemid 30194389)
3. Oñate-Ocaña LF, Aiello-Crocifoglio V, Mondraǵon- Śanchez R, et al. Survival benefit of D2 lympadenectomy in patients with gastric adenocarcinoma. Ann Surg Oncol. 2000;7:210-217. (Pubitemid 30215160)
4. De Gara CJ, Hanson J, Hamilton S. A population-based study of tumor-node relationship, resectionmargins, and surgeon volume on gastric cancer survival. Am J Surg. 2003;186:23-27. (Pubitemid 36773993)
5. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma, 2nd English Edition. Gastric Cancer. 1998;1:10-24.
6. Mansfield PF. Lymphadenectomy for gastric cancer. J Clin Oncol. 2004;22:2759-2761. (Pubitemid 41079890)
7. Dent DM, Madden MV, Price SK. Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg. 1988;75:110-112. (Pubitemid 18078521)
8. Robertson CS, Chung SC, Woods SD, et al. A prospective randomized trial comparing R1 subtotal gastrectomywith R3 total gastrectomy for antral cancer. Ann Surg. 1994;220:176-182. (Pubitemid 24309416)
9. Bonenkamp JJ, Songun I, Hermans J, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet. 1995;345:745-748.
10. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-termresults of theMRCrandomized surgical trial. Surgical Co-operative Group. Br J Cancer. 1999;79:1522-1530. (Pubitemid 29116815)
11. Degiuli M, Sasako M, Calgaro M, et al. Italian Gastric Cancer Study Group. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol. 2004;30:303-308. (Pubitemid 38425649)
12. Wu CW, Hsiung CA, Lo SS, et al. Randomized clinical trial of morbidity after D1 and D3 sugery for gastric cancer. Br J Surg. 2004;91:283-287. (Pubitemid 38375766)
13. Wu CW, Hsiung CA, Lo SS, et al. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol. 2006;7:309-315.
14. Soga J, Kobayashi K, Saito J, et al. The role of lymphadenectomy in curative surgery for gastric cancer. World J Surg. 1979;3:701-708. (Pubitemid 10206822)
15. Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg. 1987;11:418-425. (Pubitemid 17137100)
16. Moher D, Liberati A, Tetzlaff J, et al. The PRISMA Group. Preferred reporting items for systematic reviews and meta-analysis: the PRISMA statement. PLoS Med. 2009;6:e1000097.
17. Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of metaanalyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999;354:1896-1900.
18. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17: 1-12. (Pubitemid 26120810)
19. Liu IM, Agresti A.Mantel-Haenszel-type inference for cumulative odds ratios with a stratified ordinal response. Biometrics. 1996;52:1223-1234. (Pubitemid 26425274)
20. Sutton AJ, Abrams KR, Jones DR, et al. Methods forMeta-Analysis in Medical Research. John Wiley: Chichester; 2000.
21. Wermuth N, Cochran WG. Detecting systematic errors in multi-clinic observational data. Biometrics. 1979;35:683-686.
22. Hedges LV, Olkin I. Statistical Methods forMeta Analysis. Orlando: Academic Press; 1985.
23. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002,15;21(11):1539-1558 (Pubitemid 34746062)
24. Huedo-Medina TB, Śanchez-Meca J, Maŕ?n-Mart́?nez F, et al. Assessing heterogeneity in meta-analysis: qtatistic or I2 index? Psychol Methods. 2006;11:193-206. (Pubitemid 44001277)
25. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.
26. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634. (Pubitemid 27387172)
27. Tang JL, Liu JL. Misleading funnel plot for detection of bias in meta-analysis. J Clin Epidemiol. 2000;53:477-484. (Pubitemid 30254343)
28. R: A language and environment for statistical computing [computer program]. Version 2
29. 8.0. Vienna: Foundation for Statistical computing; 2008.
30. Lumley T. The rmeta Package Version 2
31. http://cran.rproject.org/web/ packages/rmeta/index.html. Accessed April 9, 2010.
32. Maruyama K. Surgical Treatment and End Results of Gastric Cancer. Toyko: National Cancer Center Press 1985: 7-24.
33. Bonenkamp JJ, Hermans J, Sasako M, et al. Quality control of lymph node dissection in the Dutch randomized trial of D1 and D2 lymph node dissection for gastric cancer. Gastric Cancer. 1998;1:152-159.
34. Solomon MJ, Laxamana A, Devore L, et al. Randomized controlled trials in surgery. Surgery. 1994;115:707-712. (Pubitemid 24189766)
35. McLeod RS, Wright JG, Solomon MJ, et al. Randomized controlled trials in surgery: issues and problems. Surgery. 1996;119:483-486. (Pubitemid 26141021)
36. Horton R. Surgical research or comic opera: questions, but fewanswers. Lancet. 1996;347:984-985. (Pubitemid 26112164)
37. Edwards P, Blackshaw GR, Lewis WG, et al. Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma. Br J Cancer. 2004;90:1888-1892. (Pubitemid 38746326)
38. Lewis WG, Edwards P, Barry JD, et al. D2 or not D2? The gastrectomy question. Gastric Cancer. 2002;5:29-34. (Pubitemid 34496349)
39. D́?az de Liaño A, Yarnoz C, Aguilar R, et al. Rationale for gastrectomy with D2 lymphadenectomy in the treatment of gastric cancer. Gastric Cancer. 2008;11:96-102. (Pubitemid 351931667)
40. Sue-Ling HM, Johnston D, Martin IG, et al. Gastric cancer: a curable disease in Britain. BMJ. 1993;307:591-596. (Pubitemid 23255064)
41. Pacelli F, Doglietto GB, Bellantone R, et al. Extensive versus limited lymph node dissection for gastric cancer: a comparative study of 320 patients. Br J Surg. 1993;80:1153-1156. (Pubitemid 23284047)
42. Siewert JR, B̈ottcher K, Roder JD, et al. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Br J Surg. 1993;80:1015-1018. (Pubitemid 23261584)
43. Sue-Ling HM, Johnston D. D1 versus D2 dissection for gastric cancer. Lancet. 1995;345:1515-1516.
44. Wu CW, Hsieh MC, Lo SS, et al. Results of curative gastrectomy for carcinoma of the distal third of the stomach. J Am Coll Surg. 1996;183:201-207.
45. Imamura Y, Yoshimi I. Comparison of cancer mortality (stomach cancer) in five countries; France, Italy, Japan, UK and USA from the WHO mortality database (1960-2000). Jpn J Clin Oncol. 2005;35:48-51. (Pubitemid 40450557)
46. http://seer.cancer.gov/statfacts/html/stomach.html. Accessed April 9, 2010.
47. http://info.cancerresearchuk.org/cancerstats/types/stomach/index.htm? script =true. Accessed April 9, 2010.
48. http://www.cancer.org/downloads/STT/Global-Facts-and-Figures-2007-rev2. pdf. Accessed April 9, 2010.
49. Nitti D, Marchet A, Mammano E, et al. Extended lymphadenectomy (D2) in patients with early gastric cancer. Eurp J Surg Oncol. 2005;31:875-881. (Pubitemid 41435257)
50. Itoch H, Oohata Y, Nakamura K, et al. Complete ten-year postgastrectomy follow-up of early gastric cancer. Am J Surg. 1989;158:14-16. (Pubitemid 19178308)
51. Yoshikawa T, Tsuburaya A, Kobayashi O, et al. Is D2 lymph node dissection necessary for early gastric cancer? Ann Surg Oncol. 2002; 9: 401-405. (Pubitemid 34496729)
52. Bunt AMG, Hermans J, Boon MC, et al. Evaluation of the extent of lymphadenectomy in a randomized trial of Western-versus Japanese-Type surgery in gastric cancer. J Clin Oncol. 1994;12:417-422. (Pubitemid 24056418)
53. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques are a source of misleading statistics for survival in cancer. N Engl J Med. 1985;312:1604-1608. (Pubitemid 15062653)
54. Volpe CM, Koo J, Miloro SM, et al. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma. J Am Coll Surg. 1995;181:56-64.
55. Songun I, Putter H, Kranenbarg EM, et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11:439-449.
56. Bunt TMG, Bonenkamp HJ, Hermans J, et al. Factors influencing noncompliance and contamination in a randomized trial of "Western" (r1) versus "Japanese" (r2) type surgery in gastric cancer. Cancer. 1994;73:1544-1551. (Pubitemid 24085252)
57. Yildirim E, Celen O, Berberoglu U. The Turkish experience with curative gastrectomies for gastric carcinoma: is D2 dissection worthwhile? J Am Coll Surg. 2001;192:25-37. (Pubitemid 32064095)
58. Danielson H, Kokkola A, Kiviluoto T, et al. Clinical outcome after D1 vs D2-3 gastrectomy for treatment of gastric cancer. Scand J Surg. 2007;96:35-40. (Pubitemid 46493762)
59. Aiko T, Sasako M. The new Japanese Classification of Gastric Carcinoma: Points to be revised. Gastric Cancer. 1998;1:25-30.
60. Csendes A, Burdiles P, Rojas J, et al. A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma. Surgery. 2002;131:401-407. (Pubitemid 34289730)
61. Maruyama K, Sasako M, Knishita T, et al. Pancreas-Preserving total gastrectomy for proximal gastric cancer. World J Surg. 1995;19:532-536.
62. Machara Y, Moriguchi S, Yoshida M, et al. Splenectomy does not correlate with length of survival in patients undergoing curative total gastrectomy for gastric carcinoma. Cancer. 1991;67:3006-3009.
63. Kodera Y, Yamamura Y, Shimizu Y, et al. Lack of benefit of combined pancreato-splenectomy in D2 resection for proximal third gastric cacner. World J Surg. 1997;21:622-628. (Pubitemid 27268559)
64. Kinoshita T, Maruyama K, SasakoM, et al. Lymph node dissection around the splenic artery: a comparative study of pancreatectomy and pancreas preserving operation. Nippon Geka Gakkai. 1992;93:128-132.
65. Okayima K, Isozaki H. Splenectomy for treatment of gastric cancer; Japanese experience. World J Surg. 1995;19:537-540.
66. Yu W, Choi GS, Chung HY. Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer. Br J Surg. 2006;93:559-563.
67. Adachi Y, Kamakura T, Mori M, et al. Role of lymph node dissection and splenectomy in node positive gastric carcinoma. Surgery. 1994;116:837-841. (Pubitemid 24347191)
68. Griffith JP, Sue-Ling HM, Martin I, et al. Preservation of the spleen improves survival after radical surgery for gastric cancer. Gut. 1995;36:684-690.
69. Kwon SJ. Prognostic impact of splenectomy on gastric cancer: results of the Korea gastric cancer study group. World J Surg. 1997;21:837-844. (Pubitemid 27407427)
70. Lee KY, Noh SH, Hyung WJ, et al. Impact of splenectomy for lymph node dissection on long-term surgical outcome in gastric cancer. Ann Surg Oncol. 2001;8:402-406.
71. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455-463. (Pubitemid 30422636)
72. Sauerland S, Seiler CM. Role of systematic reviews and meta-analysis in evidence-based medicine. World J Surg. 2005;29:582-587. (Pubitemid 41187393)
73. Greenland S. Invited commentary: a critical look at some popular meta-analytic methods. Am J Epidemiol. 1994;140:290-296
74. Stern JA, EggerM. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemol. 2001;54:1046-1055. (Pubitemid 32888370)
75. Higgns JP, Green S. Analysing and Presenting Results. Cochran's Handbook for Systematic Reviews of Interventions 4 2.6 (updated September 2006). Section
76. In: The Cochrane Library, Issue 4. Chichester, UK; JohnWiley & Sons Ltd. 2006.
77. Ioannidis JP, Lau J. Can quality of clinical trials and meta-analyses be quanti- fied? Lancet. 1998;352:590-591. (Pubitemid 28380134)
78. Ng TT, McGory ML, Ko CY, et al. Meta-analysis in surgery: methods and limitations. Arch Surg. 2006;141:1125-1130; discussion 1131. (Pubitemid 44790544)
79. Smith GD, Egger M. Incommunicable knowledge? Interpreting and applying the results of clinical trials and meta-analyses. J Clin Epidemiol. 1998;51:289-295. (Pubitemid 28156044)
80. Ioannidis JP, Patsopoulos NA, Evangelou E. Uncertainty in heterogeneity estimates in meta-analyses. BMJ. 2007;335:914-916. (Pubitemid 350076978)